feed,title,long_url,short_url
Benzinga,Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study,https://benzinga.com/general/biotech/22/01/25002882/lexaria-bioscience-nasdaq-lexx-receives-independent-review-board-approval-for-human-study,https://j.mp/3tiAStz
